Figure 5.KEGG pathway enrichment analysis of differentially expressed serum metabolites in the AR model mice treated with YJD and dexamethasone. (A–D) KEGG enrichment analysis results show the top enriched KEGG pathways based on the differentially expressed serum metabolites between (A) control and AR model, (B) control and AR model plus YJD, (C) AR model and AR model plus YJD, and (D) AR model and AR model plus dexamethasone groups.
